Olivier Danos
2021
In 2021, Olivier Danos earned a total compensation of $2.8M as EVP, Chief Scientific Officer at Regenxbio, a 55% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $239,192 |
| Option Awards | $1,433,958 |
| Salary | $455,604 |
| Stock Awards | $521,652 |
| Other | $47,288 |
| Total | $2,797,694 |
Danos received $1.4M in option awards, accounting for 51% of the total pay in 2021.
Danos also received $100K in bonus, $239.2K in non-equity incentive plan, $455.6K in salary, $521.7K in stock awards and $47.3K in other compensation.
Rankings
In 2021, Olivier Danos' compensation ranked 4,704th out of 12,405 executives tracked by ExecPay. In other words, Danos earned more than 62.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,704 out of 12,405 | 62nd |
Division Manufacturing | 1,953 out of 5,494 | 65th |
Major group Chemicals And Allied Products | 816 out of 2,369 | 66th |
Industry group Drugs | 729 out of 2,090 | 65th |
Industry Biological Products, Except Diagnostic Substances | 185 out of 452 | 59th |
Pay ratio
| Olivier Danos' Pay | $2,797,694 |
|---|---|
| Median Employee's Pay | $176,342 |
| Pay Ratio | 16to 1 |
In 2021, the annual total compensation of Olivier Danos was $2,797,694.
The annual total compensation of the median employee at Regenxbio was $176,342.
The ratio of Olivier Danos' pay to the pay of median employee was therefore 16 to one.
Source: SEC filing on April 7, 2022.
Danos' colleagues
We found four more compensation records of executives who worked with Olivier Danos at Regenxbio in 2021.